Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. (NASDAQ: HSIC) generates a steady flow of news as a FORTUNE 500 and S&P 500® health care solutions company serving office-based dental and medical practitioners. As a medical, dental, and hospital equipment and supplies merchant wholesaler with a significant technology footprint, the company issues updates that cover financial performance, leadership changes, partnerships, and product and technology developments.
Investors following HSIC news will find regular earnings and guidance announcements, including quarterly financial results and updates on sales growth across its Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments. These releases often highlight trends in dental and medical distribution, specialty dental products, and technology adoption, as well as commentary on strategic initiatives such as the company’s BOLD+1 strategy and value creation programs.
Henry Schein news also includes leadership and governance updates, such as the announced retirement of long-time CEO Stanley M. Bergman from the chief executive role and the appointment of Frederick M. Lowery as the company’s next CEO, effective March 2, 2026. These items provide insight into succession planning and the company’s approach to long-term leadership continuity.
Another key theme in HSIC coverage is technology and innovation in dental practice management. Through Henry Schein One, the company reports on new AI-enabled workflows, embedded automation, and collaborations with partners like Amazon Web Services and VideaHealth. News items describe developments in practice management platforms such as Dentrix and Dentrix Ascend, including AI-driven documentation, imaging, and revenue cycle tools.
In addition, Henry Schein announces strategic partnerships and distribution agreements, such as its expanded relationship with vVARDIS for the Curodont Repair Fluoride Plus product across U.S. dental segments. These stories shed light on how the company broadens its product offerings and supports dental professionals with new clinical options.
For investors, analysts, and health care professionals, the HSIC news feed on Stock Titan offers a centralized view of these corporate developments, helping users monitor how Henry Schein’s distribution, specialty products, and technology initiatives evolve over time.
Henry Schein (Nasdaq: HSIC) has been recognized by Ethisphere as one of the 2021 World’s Most Ethical Companies, marking its 10th consecutive year as a honoree and the only recognition in the Healthcare Products industry. With over 19,000 Team Schein Members, the company emphasizes ethical practices as foundational to its success. Ethisphere's Ethics Index indicates honorees outperformed a comparable index by 7.1 percentage points from January 2016 to January 2021. Henry Schein operates in 31 countries, providing solutions to over 1 million customers with $10.1 billion in sales in 2020.
Henry Schein (Nasdaq: HSIC), the largest provider of health care solutions, will present virtually at the 2021 Barclays Global Healthcare Conference on March 9, 2021, at 2:25 p.m. Eastern time. Interested parties can access the live webcast at www.henryschein.com/IRwebcasts. A replay will be available afterward. With over 19,000 Team Schein Members, Henry Schein serves more than 1 million customers globally, delivering 300+ solutions to improve efficiency and clinical outcomes in the dental and medical sectors.
Summary not available.
Henry Schein reported fourth quarter 2020 net sales of $3.2 billion, an increase of 18.6% from Q4 2019, driven by demand for PPE and COVID-19 products. GAAP net income was $141.9 million or $0.99 per diluted share, down from $330.6 million or $2.25 per diluted share a year earlier. Non-GAAP net income rose slightly to $143.6 million or $1.00 per diluted share. Operating margins suffered from inventory adjustments and an $18.1 million impairment charge. 2021 non-GAAP EPS guidance is set at or above $3.51, excluding potential restructuring costs.
Henry Schein One has appointed Mike Baird as Chief Executive Officer, aiming to enhance growth and drive digital innovations in the dental sector. Baird, who joined the company in July 2020 as Executive Advisor, will lead all business aspects and integrate solutions across Henry Schein's offerings. His experience in health care information technology positions him as a key player in advancing the company’s mission to improve practice management and patient engagement. The leadership change is expected to strengthen the firm’s commitment to customer-focused solutions.
Henry Schein, the leading provider of healthcare solutions, announced the appointment of Mohamad Ali and Deborah Derby to its Board of Directors until the 2021 Annual Meeting. They will stand for re-election at that time. The company also confirmed the retirement of Paul Brons and the non-re-election of Shira Goodman due to other commitments, both of whom have contributed significantly to the company's growth. Ali and Derby bring extensive experience in technology and operational leadership, expected to advance the company's strategic goals.
Henry Schein (Nasdaq: HSIC) will announce its fourth quarter and full-year 2020 financial results on February 17, 2021, before the market opens. A live webcast of the earnings conference call is scheduled for the same day at 10:00 a.m. Eastern time, featuring CEO Stanley M. Bergman and CFO Steven Paladino. Investors can access the call through the company's website, with a replay available post-event. Henry Schein, a Fortune 500 company, provides healthcare solutions to dental and medical practitioners globally, reporting sales of $10 billion in 2019.
Summary not available.
Summary not available.
Henry Schein, Inc. (HSIC) has acquired a majority stake in Prism Medical Products, LLC, a provider of specialty home medical supplies, particularly in advanced wound care. This acquisition expands Henry Schein Medical’s reach into the multibillion-dollar home medical equipment market. Prism, founded in 2006, reported approximately $52 million in net revenue for the year ending September 30, 2020. The acquisition is expected to be neutral to earnings in 2021 and accretive thereafter. PRISM will operate as a subsidiary managed by its founder Chris Cartwright.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
